These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 34389530

  • 1. The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis.
    Song S, Yang W, Tian H, Gong S, Lei C, Lv K, Lu T, Cheng Q, Yang K, Guo T.
    Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101788. PubMed ID: 34389530
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers.
    Rhodin KE, Liu A, Bartholomew A, Kramer R, Parameswaran A, Uronis H, Strickler J, Hsu D, Morse MA, Shah KN, Herbert G, Zani S, Nussbaum DP, Allen PJ, Lidsky ME.
    Ann Surg Oncol; 2023 Aug; 30(8):4813-4821. PubMed ID: 37188803
    [Abstract] [Full Text] [Related]

  • 9. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
    Woo SM, Lee WJ, Han SS, Park SJ, Kim TH, Koh YH, Kim HB, Hong EK, Park JW, Kim CM.
    Chemotherapy; 2012 Aug; 58(3):225-32. PubMed ID: 22831988
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers.
    Ma WJ, Jin YW, Wu ZR, Yang Q, Wang JK, Liu F, Shi YJ, Li QS, Cheng NS.
    HPB (Oxford); 2020 Jul; 22(7):939-949. PubMed ID: 32349925
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Systematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancer.
    Zhu GQ, Shi KQ, You J, Zou H, Lin YQ, Wang LR, Braddock M, Chen YP, Zheng MH.
    Aliment Pharmacol Ther; 2014 Oct; 40(7):759-70. PubMed ID: 25099956
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical efficacy of adjuvant treatments for patients with resected biliary tract cancer: a systematic review and network meta-analysis.
    Chen Y, Zhang B, Liu C, Cao Y, Lyu C, Qiu M.
    BMJ Open; 2022 Apr 19; 12(4):e051421. PubMed ID: 35440445
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.
    Horgan AM, Amir E, Walter T, Knox JJ.
    J Clin Oncol; 2012 Jun 01; 30(16):1934-40. PubMed ID: 22529261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.